COMPARATIVE STUDY BETWEEN BELOTECAN/CISPLATIN AND ETOPOSIDE/CISPLATIN (COMBAT) IN PATIENTS WITH PREVIOUSLY UNTREATED, EXTENSIVE STAGE SMALL CELL LUNG CANCER

被引：0

作者：

Oh, In-Jae ^{[1
]}

Kim, Kyu-Sik ^{[1
]}

Kim, Young-Chul ^{[1
]}

Na, Kook-Joo ^{[1
]}

Ahn, Sung-Ja ^{[1
]}

Song, Sang-Yun ^{[1
]}

Choi, Yoo-Duk ^{[1
]}

Yoon, Seong-Hoon ^{[1
]}

Lee, Boram ^{[1
]}

Yu, Jinyeong ^{[1
]}

机构：

[1] Chonnam Natl Univ, Hwasun Hosp, Lung Canc Clin, Kwangju, South Korea

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

belotecan; small cell lung cancer; topoisomerase I inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.10-031

引用

页码：S1171 / S1171

页数：1

共 50 条

[31] A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer
Yeo, Chang Dong
Lee, Sang Haak
Kim, Ju Sang
Kim, Seung Joon
Kim, Seok Chan
Kim, Young Kyoon
Kang, Hyeon Hui
Yoon, Hyung Kyu
Song, Jeong Sup
Moon, Hwa Sik
Kim, Jin Woo
Kim, Kwan Hyoung
Shim, Byoung Yong
Kim, Chi Hong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 809 - 814
[32] A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer
Chang Dong Yeo
Sang Haak Lee
Ju Sang Kim
Seung Joon Kim
Seok Chan Kim
Young Kyoon Kim
Hyeon Hui Kang
Hyung Kyu Yoon
Jeong Sup Song
Hwa Sik Moon
Jin Woo Kim
Kwan Hyoung Kim
Byoung Yong Shim
Chi Hong Kim
Cancer Chemotherapy and Pharmacology, 2013, 72 : 809 - 814
[33] A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
Masahiro Tabata
Katsuyuki Kiura
Niro Okimoto
Yoshihiko Segawa
Tetsu Shinkai
Toshiro Yonei
Shoichi Kuyama
Shingo Harita
Katsuyuki Hotta
Hiroshi Ueoka
Mitsune Tanimoto
Cancer Chemotherapy and Pharmacology, 2007, 60 : 1 - 6
[34] A MULTICENTER PHASE II STUDY OF BELOTECAN, A NEW CAMPTOTHECIN ANALOGUE, IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED, EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Yeo, Chang Dong
Choi, Si Young
Lee, Sang Haak
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1230 - S1230
[35] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
Noda, W
Nishiwaki, Y
Kawahara, M
Negoro, S
Sugiura, T
Yokoyama, A
Fukuoka, M
Mori, K
Watanabe, K
Tamura, T
Yamamoto, S
Saijo, N
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02): : 85 - 91
[36] A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
Tabata, Masahiro
Kiura, Katsuyuki
Okimoto, Niro
Segawa, Yoshihiko
Shinkai, Tetsu
Yonei, Toshiro
Kuyama, Shoichi
Harita, Shingo
Hotta, Katsuyuki
Ueoka, Hiroshi
Tanimoto, Mitsune
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 1 - 6
[37] ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN IN EXTENSIVE SMALL-CELL LUNG-CANCER
LOEHRER, PJ
RYNARD, S
ANSARI, R
SONGER, J
PENNINGTON, K
EINHORN, L
CANCER, 1992, 69 (03) : 669 - 673
[38] RANDOMIZED COMPARISON OF LOBAPLATIN PLUS ETOPOSIDE AND CISPLATIN PLUS ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Guo, Feng W.
Liao, Qing G.
Gao, Jun H.
Wang, Mei H.
Tang, Hao C.
Qing, Peng H.
Li, Jie J.
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S493 - S493
[39] Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC) - A multicenter phase II study
Mavroudis, D
Veslemes, M
Kouroussis, C
Tzanakis, N
Ferdoutsis, E
Toumbis, M
Ziotopoulos, P
Agelidou, M
Tselepatiotis, E
Kalbakis, K
Souglakos, J
Magkanas, E
Samonis, G
Georgoulias, V
LUNG CANCER, 2002, 38 (01) : 59 - 63
[40] Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: A University of Colorado Cancer Center Study
Bunn, PA
Kelly, K
SEMINARS IN ONCOLOGY, 1996, 23 (06) : 11 - 15

← 1 2 3 4 5 →